Materials and Methods
Mice. Adult mice, 6-10 wk of age, were used in these experiments. C57BL/6 mice (B6)
were purchased from The Jackson Laboratory, Bar Harbor, Maine. The B10.A and B6.K1 strains were inbred strains obtained from the colony maintained at The University of Texas Health Science Center at Dallas.
Antisera. Antisera reactive against Qa-2 were prepared by immunizing B6.K1 mice with B6 spleen and lymph node cells as described previously (6) . The [B10.A (5R) × R III]F1 a B10 antiserum (aD b) was obtained from the Research Resources Branch of the National Institutes of Health, Bethesda, Md. All other anti H-2 alloantisera were prepared by immunizing the appropriate recipients with donor spleen and lymph node cells as described in Table I . Anti-H-2D vs. anti-H-2K activity was determined by immunoprecipitation analysis of lysates from spleens of appropriate recombinant mice. Rabbit anti-mouse immunoglobulin (RAMIg) and goat anti-mouse immunoglobulin (GAMIg) were prepared as described previously (17, 18) . Normal mouse serum (NMS; Pel-Freeze Biologicals Inc., Rogers, Ariz.) was obtained from outbred mice.
Preparation and Labeling of Mitogen-activated Spleen Cells. Mouse spleens were teased into Hanks'
balanced salt solution (HBSS) and single cell suspensions were prepared as described previously (19) . Cell viability was assessed using trypan blue exclusion. Concanavalin A (Con A)-aetivated spleen cells were routinely prepared by resuspending 7.2 × 10 s viable cells in 200 ml RPMI-1640 containing 5% fetal calf serum (FCS), 5 pg/ml Con A (ICN Nutritional Bioehemicals, Cleveland, Ohio), 5 × 10 -s M 2-mercaptoethanol (2-ME), glutamine, and antibiotics. To s obtain lipopolysaccharide (LPS)-activated cells, 3 × I0 viable spleen cells were resuspended in 150 ml RMPI-1640 containing 20% FCS, 5 × 10 -5 M 2-ME, 2× nonessential amino acids and glutamine, 1 mM sodium pyruvate, 50 #g/ml LPS (Salmonella typhosa 0901; Difco Laboratories, Detroit, Mich.), and antibiotics. The cultures were then gassed with 10% CO2 and incubated for 48 h at 37°C.
The mitogen-activated cells were harvested and labeled at 1 × l0 T cells/ml for 8 h with aH (150 /xCi/ml) or t4C (15 /~Ci/ml) amino acids (New England Nuclear, Boston, Mass. or Amersham-Searle Corp., Arlington Heights, Ill.) as detailed elsewhere (20) . Labeled cells were harvested by centrifugation, washed twice in Tris-buffered saline (TBS), pH 7.4, and lysed for 15 rain at 4°C in 5-6 ml TBS containing 0.5% nonidet P-40 (NP-40; Gallard, Schlesinger, New York). Nuclei and debris were subsequently removed by centrifugation for 15 rain at 2,000 g. (20) . Lentil-lectin was purified from Lens culinaris and coupled to Sepharose 4B as described previously (21) . Lysates were applied to the lectin column in TBS containing 0.25% NP-40 and the nonadherent proteins were eluted in the same buffer. The adherent material was eluted with 0.3 M amethylmannoside in TBS with 0.25% NP-40, and concentrated to ~5 ml by negative-pressure dialysis.
The concentrated glycoprotein pools were centrifuged at 10,000 g for 15 rain before immunoprecipitation. Immunoglobulin was immunoprecipitated from the concentrated glycoprotein pool by incubation with RAMIg (300 #1/3 × l0 s cells) for 15 min at 37°C and 30 min at 4°C. Immune complexes were removed by the addition of protein A-bearing Cowan I strain of Staphylococcus aureus, followed by incubation for 15 min at 37°C and 30 min at 4°C (22) . Immunoglobulin-depleted glycoprotein pools were then depleted of"nonspecific" material by adding NMS (250#1/3 × 10° cells) for 15 rain at 37°C and 30 rain at 4°C, followed by two treatments with S. aureus. "Preeleared" glycoprotein pools were then reacted with the appropriate alloantisera at 37°C for 15 min and 4°C for 2-12 h. All alloantisera were titered so as to remove all reactive molecules. Immune complexes were removed by either immunoprecipitating them with GAMIg or by absorbing them to S. aureus. Immunoprecipitates or S. aureus-bound complexes were washed three times with TBS containing 0.1% sodium dodecyl sulfate (SDS), 0.25% NP-40, and 0.2% deoxycholate, followed by one wash with TBS. Immune complexes were eluted from the S. aureus or immune precipitates were dissolved by boiling for 2 min in electrophoresis sample buffer with 5% 2-ME. All insoluble material was removed by centrifugation at 10,000 g for 5 rain. Samples were electrophoresed for 4-5 h on 12.5% polyacrylamide gels using the Laemmli discontinuous system as described previously (23) . All gels were fractionated using a Savant gel crusher (Savant Instruments Inc., Hicksville, N. Y.). In some experiments, gels were fractionated directly into scintillation vials and then counted in Beckman EP cocktail (Beckman Instruments Inc., Fullerton, Calif.). Alternatively, the fractionated gels were incubated overnight in 0.01% SDS to allow the radiolabeled protein to elute from the gel matrix. Aliquots of each fraction were then removed and counted in scintillation cocktail. The appropriate fractions were pooled, gel pieces were removed by filtration through a 0.45-# Millipore filter (Millipore Corp., Bedford, Mass.), and the samples were then lyophilized.
Preparation and Use of Sepharose-GAMlg. GAMIg serum (10) was affinity-purified on Sepharose-mouse euglobulin and coupled at 1 mg/ml to cyanogen-activated Sepharose 4B (24) .
Trypsin Digestion and Comparative Peptide Mapping. The techniques described below have been detailed elsewhere (25, 26) . Lyophilized H-2D, H-2K, or Qa-2 molecules were redissolved in 2-3 ml dH20 containing 0.5-1.0 mg human gammaglobulin (HGG) as carrier and dialyzed against several changes of 0.1 M NH, HCOs, pH 8.0. The molecules to be compared (e.g., all-14 3 14 Qa-2 and C-H-2K~ were then mixed at a H: C ratio of 2-3:1 and relyophilized. The lyophilized samples were dissolved in 1.0 ml 0.1 M NH4HCOs, pH 8.0, and 20 #g TPCKtrypsin was added. After a 1-h incubation at 37°C, additional trypsin (100-200 #g) was added and the incubation was continued for 12-16 h at 37°C. The pH was then lowered by the addition of 2-3 drops of glacial acetic acid and the sample was lyophilized. Before chromatography, the peptides were solubilized in 2.0 ml 0.05 M pyridine acetate (PA), pH 3.13. Insoluble material was removed by centrifugation at 10,000 g for 5 min. Routinely 75-95% of the input cpm were recovered in the acid soluble fraction. Tryptic peptides were analyzed by cation exchange chromatography on Teehnicon chromobeads type P (Technicon T & T Corp., McFaxland, Wis.), using a 3-× 150-mm microbore column maintained at 54°C by a water jacket. The solubilized peptides were applied to the column in 0.05 M PA, pH 3.13. After washing the column with 5-6 ml of starting buffer, a pH-ionic strength gradient was applied using a Varigard gradient maker (Phoenix Precision Instruments, Gardiner, N. Y.). 30 ml of each of the following PA buffers was used: 0.05 M, pH 3.13; 0.1 M, pH 3.54; 0.2 M, pH 4.02; 0.5 M, pH 4.50; 2.0 M, pH 5.0. After completion of the gradient, 2-3 ml of 2 N NaOH was applied to remove all bound material. 12 drop fractions were collected into minivials and allowed to evaporate. Water (0.35 ml) and scintillation fluid were added and the samples were counted. The H and 14C cpm were normalized and corrected for channel spillover.
Results
Isolation of Qa-2 and H-2 Molecules. The Qa-2 antigen is expressed on subpopulations of lymphocytes and the surface density is several-fold lower than H-2D or H-2K antigens, as determined by immunopreeipitation of radiolabeled molecules from cell lysates (15) . Hence, it was important to obtain a population of lymphocytes that was enriched for Qa-2 antigens. Studies by Flaherty et al. (11) have demonstrated that 75-90% of the cells in populations of mitogen (Con A, phytohemagglutinin [PHA], LPS)-activated lymphocytes express serologically detectable Qa-2. Therefore, Con Astimulated spleen cells were used for preparation of Qa-2 molecules. An SDS gel profile of a typical immunopreeipitate using extracts prepared from B6 Con A blasts is shown in Fig. 1A . As demonstrated earlier (15), B6. KlaB6 (aQa-2) serum recognizes a polypeptide of-44,000 mol wt. fl-2 microglobulin, which is known to be associated with Qa-2 molecules, was allowed to migrate off the gel under the electrophoretic conditions employed. When glycoproteins pools from B6.K1 (Qa-2-) Con A blasts were treated with og~.a-2, no peak corresponding to 44,000 mol wt is precipitated, thus establishing the specificity of our antisera (Fig. 1B) . When glycoproteins from B6 Con A blasts were precipitated with NMS, a significant amount of material migrating at 44,000 mol wt could also be detected. Thus radioactive material, presumably nonQa-2 in nature, could contaminate our Qa-2 preparations and thereby interfere with subsequent structural analysis. Additional experiments demonstrated that the material that was nonspecifically precipitated could be significantly reduced by preincubating glycoprotein pools with NMS and S. aureus. Under the preclearing conditions, a maximum of 5-10% of the 44,000-mol wt peak could represent nonspecific contamination. Sears et al. (27) reported a similar problem in their structural studies of the H-2L alloantigen, and observed that nonspecific precipitation could be reduced by preincubating the lysate with NMS coupled to Sepharose.
H-2K or H-2D alloantigens were immunoprecipitated from mitogen-stimulated B10.A or B6 spleen cells. Preliminary experiments revealed that the preclearing regimen was applicable to the isolation of 1-1-2 gene products. The anti-H-2 sera used are complex and contain reactivities toward H-2K, D, and I region determinants (Table I) . However, by selecting the appropriate recombinant congenic strain, specific ) or NMS (-----). Immunoprecipitates were formed by the addition of GAMIg and subsequently were washed, solubilized, reduced, and analyzed on 12.5% polyacrylamide gels.
for the K or D end antigens of the H-2 complex, specific immunoprecipitations can be obtained. For example, B10. D2otBl0. BR will contain reactivity toward determinants carried by K k, I-A k, I-E/C k, and D k (Table I) . By using B10.A (K k, D d) cells, reactivity is confined to the K end. Any I region-controlled molecules that are coprecipitated can be readily separated from H-2 by SDS-polyacrylamide gel electrophoresis (PAGE) (see Fig. 2A and B) . The results of these experiments are shown in Fig. 2 . Under conditions in which 95-100% of the Qa-2 was removed (Fig. 2E and F) , there was no removal of immunoprecipitable H-2D b (Fig. 2C and D) or H-2K b ( Fig. 2A and B) . This result T~yptic Peptides of Isolated [~H] arginine-labeled Qa-2 Molecules. Qa-2 molecules labeled with [Sill-or [Z4C]arginine were isolated from B6-Con A blasts and digested with trypsin as described in Materials and Methods. Each digest was analyzed by cation exchange chromatography employing a PA pH-ionic strength gradient. Fig. 3 (top) shows a peptide map in which [nH]arginine-and [14C]arginine-labeled Qa-2 were coanalyzed. 11-13 arginine peptides can be reproducibly resolved when Qa-2 molecules are digested and analyzed. The last peak in each map represents material eluted from the column by 2 N NaOH. The amount of radioactivity recovered in this peak was variable and is not scored as a peptide in this analysis. Routinely 85-95% of the input radioactivity is soluble in the acidic (pH 3.13) starting buffer, and 85-95% of this acid soluble radioactivity is recovered from the column. Thus, the vast majority of argininelabeled peptides are being detected by this analysis. It should be noted that the maps generated from [aH]arginine-or [14C]arginine-labeled Qa-2 are completely superimposable. This finding demonstrates the reproducibility of the "double-label" mapping technique. The advantage of performing a double-label analysis versus aligning pH gradients or internal markers in single-label experiments has been discussed previously (25) .
The amount of radioactivity under the majority of the peaks is approximately equal throughout the map (Fig. 3, top) . The simplest interpretation of this observation is that these peptides are derived from a single major molecular species. However, several minor peaks are observed. The aQa-2 serum used was produced by immunizing B6.K1 mice with B6 spleen and lymph node cells (6) . Therefore, this serum is potentially polyvalent with reaetivities toward Qa-2, Qa-3, Qa-4, and Qa-5 (13). Because reactivity toward Qa-4 and Qa-5 has only been observed using monoclonal antibodies (7), the minor peaks observed might be derived from a 44,000-mol wt polypeptide bearing the Qa-3 alloantigen. Alternatively, because the majority of these minor species are not always observed, some may be either incomplete trypsin digestion products or the result of occasional trypsin-mediated cleavages at tyrosine residues (28) . Nevertheless, these minor species did not detract from our studies because only major peaks were scored in the comparisons. In addition, one should note the large peak eiuting at fractions 135-140. We explored the possibility that this peak represents free arginine by mixing [SH]arginine-labeled Qa-2 with free [14C]-arginine, digesting with trypsin and analyzing the products by cation exchange chromatography. Free arginine co-chromatographed with the major Qa-2 peak (data not shown). This free arginine could have arisen from background contamination carried over during the purification procedure, or alternatively could be generated by the trypsin cleavage of adjacent arg-arg or lys-arg residues. The latter possibility seems most likely because amino acid sequence analysis of H-2K, H-2D, and H-2L alloantigens indicate several sites in which such cleavages could occur (29) (30) (31) (32) .
It is well documented that the technique of cation exchange chromatography used in our experiments is very sensitive for detecting structural differences (33) (34) (35) (36) . A single amino acid substitution in a given peptide can markedly alter its elution position from the column (34) (35) (36) . Hence, structurally distinct polypeptides should show little peptide homology. Fig. 3 (bottom) shows a peptide map comparison of Qa-2 with a mouse Ig r-chain isolated from the IgG2A~ secreted by P3 myeloma cells (37) . None of the 12 Qa-2 peptides co-eluted with peptides derived from this r-chain. The free arginine peptide is indicated by the arrow. This result confirms that structurally unrelated molecules show little or no homology at the level of comparative peptide mapping. Fig. 4 shows a comparative peptide map analysis of Qa-2 and H-2K b and H-2D b molecules. Clearly, Qa-2 is structurally distinct from H-2K b and D b because numerous peptide differences are observed. However, there are several Qa-2 peptides that co-elute with peptides derived from H-2K b or H-2D b. Thus, 5/12 (42%) and 2/12 (17%) of the Qa-2 peptides co-eluted with peptides derived from H-2K b and H-2D b, respectively. This level of peptide homology is similar to that reported for various H-2K, H-2D, and H-2L altoantigens when their tryptic peptides were compared (26, 27, 38) .
Comparison of the Arginine T~yptic Peptides of Qa-2 and H-2 Alloantigens.
Because the Qa-2 and H-2 molecules compared above were isolated from the same mouse strain, it was of interest to determine whether Qa-2 molecules have demonstrable peptide homology with H-2 molecules from another haplotype. Fig. 5 shows the comparative peptide maps of Qa-2 and H-2K k or H-2D d. Again, considerable structural homology is observed with 4/12 (33%) and 5/12 (42%) Qa-2 peptides eoeluting with H-2K k and H-2D d peptides, respectively. A summary of the peptide map comparisons of Qa-2 vs. H-2 alloantigens is shown in Table II . It should be noted that the major Qa-2 peak, which we have demonstrated to be free arginine, is not included in the peptide homology comparison of this study.
The majority of the coincident peaks have similar ratios of aH:14C. This is the expected observation if the peaks are structurally identical (33, 38) . However a few coincident peaks differ markedly in their aH:14C ratios (for example, Fig. 4 , top fractions 210-215, and Fig. 5, top fractions 170-175) . We are including these peaks in the comparisons because we cannot exclude ~ the possibility that a given peak may contain two or more peptides, one that is homologous, the other not. Indeed, the difference in the aH:14C ratio suggests that this is the case.
A third H-2 locus, H-2L, which shares public but not private specificities with H-2D alloantigens, has recently been described (39, 40) . Hence, antisera used to immunoprecipitate H-2D molecules could also detect H-2L alloantigens. We believe that it is unlikely that this complexity affects comparisons between Qa-2 and H-2D antigens for the following reasons: (a) no H-2L b alloantigen has yet been detected by immunoprecipitation (40); (b) the tryptic peptide map of H-2D a (Fig. 5, bottom) is very similar to the maps reported by Sears et al. (27; Figs. 3 and 4) in which H-2D a was immunoprecipitated using an antiserum directed against an H-2D d private specificity; and (c) previous tryptic peptide maps of samples containing both H-2D a and H-2L d showed that the H-2L a molecule represented only a very small fraction of the total radioactivity (38) . We conclude therefore that our H-2D antisera are largely recognizing private H-2D d or H-2D b determinants. Any minor peaks that could represent H-2L alloantigens were not included in the comparison. The tryptic peptide comparisons indicate that Qa-2 is structurally related to H-2K and H-2D alloantigens and that the degree of relatedness is equivalent to that observed among H-2 alloantigens (26, 27, 38) . Fig. 6 shows a peptide map comparison of the lysine-labeled tryptic peptides derived from Qa-2 and H-2K k. As observed with the arginine maps, Qa-2 is structurally distinct from H-2K k. However, homologous peptides are again observed with 3/7 (43%) Qa-2 peptides coeluting with H-2Kk-derived peptides. 
Peptide Map Comparison of Qa-2 and H-2K* Lysine-containing Peptides.

Discussion
The present results at the primary structural level indicate that the Qa-2, H-2K u, and H-2D b alloantigens isolated from C57BL6/J mice are sufficiently distinct to show that the Qa-2 alloantigen is encoded by a separate locus. In addition, there is sufficient structural homology between Qa-2 and H-2 alloantigens to prove that they evolved from a common primordial gene. Previous serological studies demonstrated that the strain and tissue distribution of Qa-2 antigens are different from any known H-2 antigens, thereby suggesting that Qa-2 and H-2 alloantigens are encoded by different loci. Genetic evidence has mapped the Qa-2 locus to the Tla region, telomeric to H-2D (5) . In addition, biochemical studies have shown that the determinants recognized by aQa-2 or all-2 alloantisera reside on separate molecular species (15; Fig. 2 ). However, all of the above information cannot formally exclude the possibility that the Qa-2 locus encodes for an enzyme that modifies an H-2 alloantigen post-translationally. Thus, when the tryptic peptides from Qa-2 and H-2 alloantigens are compared, considerable structural variation is detected. Such extensive differences are not due to differences in glycosylation, because glycopeptides are not resolved in our analysis (34) . The possibility that other modifications, such as methylation or acetylation of amino acids, could account for the structural variation observed is highly unlikely because such extensive modifications are unprecedented (41, 42) . We therefore conclude that the observed structural differences are due to variations in the amino acid sequence. This implies that the 44,000-mol wt Qa-2 polypeptide is encoded by a locus distinct from that encoding H-2K and H-2D. The comparative peptide mapping of Qa-2 antigen with several H-2 alloantigens has shown that 21-43% of their arginine-labeled tryptic peptides are homologous (Table II) . This degree of structural homology is also observed when various H-2K, H-2D, and H-2L alloantigens are compared (26, 27, 38) . Because we have no information on the size of these homologous peptides, it is possible that this homology represents only a very restricted region(s) of the molecules. However, molecules showing such levels of peptide homology have been repeatedly demonstrated to exhibit 75-90% amino acid sequence homology (29) (30) (31) (32) . It is therefore possible that Qa-2 and H-2 alloantigens will show similar degrees of amino acid sequence homology. This is the first observation that there exist genes in the Tla region that show primary structural homology to H-2K and H-2D gene products.
Two general hypotheses have been developed to explain the presence of numerous structurally related loci on the 17th chromosome (43) . The first postulates that these loci arose from duplications and subsequent divergence of a primordial gene. The alternative hypothesis states that these loci were always separate but the structural homologies are the result of convergent evolution due to common functional constraints. The finding that there are at least four loci encoding structurally related gene products (H-2D, -K, -L, and Qa-2) and additional loci encoding other potentially homologous proteins (TL, Qa-1, etc.) argues against convergent evolution and thereby makes the duplication hypothesis more attractive. The observation that there are cell surface structures resembling Qa and TL antigens on guinea pig and human lymphocytes suggests that the duplication event occurred before speciation (44) (45) (46) . The Qa-2 and H-2 alloantigens share several biochemical properties. For example, all bind ,8-2 microglobulin, all are glycosylated, and all are membrane proteins (47) . In this regard, our comparisons have detected two Qa-2 peptides that appear to have an H-2-derived homologue in all alleles and loci tested. Hence, some of the homologies observed may represent regions of the molecule involved in glycosylation, membrane attachment, or interactions with ,8-2 microglobulin. One would predict, therefore, that the Qa-1 and TL antigens would also share primary structural homology with H-2 because these proteins possess similar biochemical features (16, 18, 47) . There is abundant evidence that indicates that the T/t and H-2 complexes contain a variety of loci that are implicated in cell-cell recognition. Our findings regarding Qa-2 alloantigen suggest that there is a cluster of genes in the Tla region that encodes gene products structurally resembling H-2 alloantigens. It is therefore tempting to speculate that Qa antigens may function on hematopoietic cells as immune recognition units similar to H-2K, H-2D, and H-2L. The recent finding that cytotoxie effector T cells can be generated against Qa-1 or Qa-2 alloantigens (48, 49) supports this idea.
Summary
The Tla region located on the murine 17th chromosome controls several serologically defined cell surface antigens. These antigens, referred to as Qa-1-5 and TL, are expressed on a variety of hematopoeitic cell populations. In the present studies we have immunoprecipitated isotopically labeled Qa-2 and H-2 molecules from mitogenstimulated B6 spleen cells. Sequential immunoprecipitation experiments have shown that the determinants recognized by aQa-2, aH-2K b, and aH-2D b alloantisera reside on separate molecular species. Comparative mapping of the arginine-labeled tryptic peptides from Qa-2, H-2K b, and H-2D b molecules indicate that Qa-2 is structurally distinct but that there is considerable structural homology; 21-43% of the Qa-2 peptides co-chromatograph with peptides derived from H-2D b and H-2K b, respectively. Similar levels of homology are observed when Qa-2 is compared with H-2K k or H-2D d. The results show that the Qa-2 alloantigen is encoded by a locus separate from the loci encoding H-2K or H-2D alloantigens, but that the Qa-2, H-2K, and H-2D alloantigens are sufficiently related at the primary structural level to indicate that they evolved from a common primordial gene.
